Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd. announced that fast growing US Durable Medical Equipment provider, Aeroflow Healthcare Inc. (Aeroflow) has executed its first Lab in Lab subcontract with US-based Regional Health Diagnostics. In February 2020, Oventus announced that it had signed an agreement with Aeroflow. Under the contract, Aeroflow identified an initial 7 of its own locations at which to deploy Oventus' Lab in Lab model before launching nationally. In addition, Aeroflow signed a master agreement which would see it offer Oventus' technology under subcontracts with regional sleep groups nationwide. Under the first subcontract, Regional Health Diagnostics, a neurological testing and sleep disorders centre which operates 12 sleep lab locations across Tennessee, Georgia, Alabama, North Carolina and South Carolina, will offer Lab in Lab services at two of its locations. Scope exists to expand the agreement once the first two sites are operational. In line with other agreements, minimum quotas of 20 patients are to be treated with Oventus' O2Vent Optima per site, per month once fully operational. The agreement has a term of three years, with an automatic three year renewal, unless a party elects not to renew no later than 180 days prior to the end of the three year period. These new agreements take the total number of locations contracted under Oventus' Lab in Lab model to 51. The first two Regional Health Diagnostics locations are based in the US state of Tennessee, which is currently in the process of lifting orders governing sheltering from COVID-19. Oventus and Aeroflow are working with the Regional Health Diagnostics sleep labs to commence identifying patients for treatment ahead of formal launch.